Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
cell-based NF-kB reporter assay from US Patent US11905258: "2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases"
Assay data:29 Active, 10 Activity ≤ 1 µM, 36 Tested
SummaryRelated BioAssays by Target
Activation of NF-kappaB (unknown origin) transfected in HEK293T cells at 0.4 to 10 uM incubated for 48 hrs by Dual-luciferase reporter gene assay
Assay data:1 Tested
Inhibition of p65 phosphorylation in LPS-induced mouse RAW264.7 cells preincubated with compound for 2 hrs followed by LPS stimulation and measured after 6 hrs by Western blot analysis
Inhibition of TNF alpha stimulated NF-KappaB in HEK293 cells using luciferase as substrate pretreated with compound followed by stimulation of TNF alpha incubated for 6 hrs and measured after substrate addition by luciferase assay
Assay data:1 Active, 1 Tested
Inhibition of NF-kB (unknown origin)
Inhibition of TNF-alpha stimulated NF-kappa B (unknown origin) activation in transfected in human K562 cells preincubated with compound for 2 hrs followed by stimulation of TNF alpha and measured after 6 hrs
Inhibition of human NF-kappaB p65 binding to DNA in LPS-stimulated human keratinocytes at 7.5 uM for 30 mins by ELISA
Inhibition of TNF-alpha induced NFkappaB activation in HEK293 cells transfected with luciferase reporter gene preincubated with compound for 10 mins followed by TNF-alpha addition and measured after 6 hrs by luciferase based assay
Assay data:1 Active, 2 Tested
Inhibition of TNF-alpha induced NFkappaB activation in HEK293 cells at 100 uM pretreated for 15 mins followed by stimulation with human recombinant TNFalpha and measured after 6 hrs by luminescence based assay relative to control
Inhibition of NFkappaB in human Jurkat cells incubated for 30 mins by bright-glo luciferase assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of cisplatin-induced phosphorylation of p65 subunit at Ser536 residue in HUVEC cells at 30 uM preincubated with eNOS inhibitor, N(G)-nitro-L-arginine methyl ester followed by compound addition and further incubated for 1 hr by Western blot analysis
Inhibition of cisplatin-induced phosphorylation of p65 subunit at Ser536 residue in HUVEC cells at 30 uM preincubated with PI3K inhibitor, wortmannin followed by compound addition and further incubated for 1 hr by Western blot analysis
Inhibition of cisplatin-induced phosphorylation of p65 subunit at Ser536 residue in HUVEC cells at 100 uM incubated for 1 hr by Western blot analysis
Inhibition of cisplatin-induced phosphorylation of p65 subunit at Ser536 residue in HUVEC cells at 30 uM incubated for 1 hr by Western blot analysis
Inhibition of cisplatin-induced NF-kappaB activation in HUVEC cell nuclear extract assessed as reduction in NF-kappaB-DNA binding activity at 30 uM incubated for 1 hr in presence of eNOS inhibitor, N(G)-nitro-L-arginine methyl ester by electrophoretic mobility shift assay
Inhibition of cisplatin-induced NF-kappaB activation in HUVEC cell nuclear extract assessed as reduction in NF-kappaB-DNA binding activity at 30 uM incubated for 1 hr in presence of PI3K inhibitor, wortmannin by electrophoretic mobility shift assay
Inhibition of cisplatin-induced NF-kappaB activation in HUVEC cell nuclear extract assessed as reduction in NF-kappaB-DNA binding activity at 100 uM incubated for 1 hr by electrophoretic mobility shift assay
Inhibition of cisplatin-induced NF-kappaB activation in HUVEC cell nuclear extract assessed as reduction in NF-kappaB-DNA binding activity at 30 uM incubated for 1 hr by electrophoretic mobility shift assay
In Vitro Kinase Activity Assay from US Patent US11691950: "Isoquinoline-steroid conjugates and uses thereof"
Assay data:21 Active, 18 Activity ≤ 1 µM, 21 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of NF-kappaB phosphorylation in human HL-60 cells at 10 uM measured after 2 hrs by Immunoblotting analysis
Assay data:5 Active, 5 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on